VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms.

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Vascular Endothelial Growth Factor (VEGF) promotes angiogenesis and is a target for ovarian cancer therapy.
• Understanding VEGF expression across ovarian neoplasm spectrum is crucial for treatment strategies.

Purpose of the Study:

• To examine VEGF expression in benign, borderline, and malignant epithelial ovarian neoplasms.
• To correlate VEGF expression with histological grade and stage in malignant cases.

Main Methods:

• A cross-sectional study of 50 epithelial ovarian neoplasms.
• Immunohistochemistry (IHC) was used to assess VEGF expression.
• VEGF expression was scored for each case.

Main Results:

• 84% of cases (42/50) showed VEGF expression.
• VEGF expression was significantly higher in carcinomas than benign/borderline neoplasms (p<0.001).
• High VEGF expression correlated with high grade (p=0.003) and stage (p=0.001).

Conclusions:

• Ovarian surface epithelial neoplasms exhibit significant VEGF expression.
• High VEGF expression is predominantly found in carcinomas, indicating potential for VEGF-targeted therapy.
• VEGF-dependent progression suggests therapeutic utility in ovarian cancer.